World's Largest Resource for Cardiovascular Perfusion
Mortality for refractory cardiogenic shock (RCS) remains high. However, with improving mechanical circulatory support device (MCSD) technology, the treatment options for RCS patients are expanding. We report on a recent 5-year single-center experience with MCSD for treatment of RCS.
Oklahoma: Tulsa-based Saint Francis Heart Hospital has switched to a “completely paperless…all-digital” network. The new system has reduced patient wait times to […]
In a double-blind randomized placebo-controlled study, the effects of intravenous glutamate infusion on myocardial haemodynamics and metabolism were studied in 22 patients […]